Utility of voriconazole therapeutic drug monitoring: a meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Utility of voriconazole therapeutic drug monitoring: a meta-analysis
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 71, Issue 7, Pages 1786-1799
Publisher
Oxford University Press (OUP)
Online
2016-05-11
DOI
10.1093/jac/dkw099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammation Is Associated with Voriconazole Trough Concentrations
- (2014) Marjolijn J. P. van Wanrooy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events
- (2013) Helen Y Chu et al. BMC INFECTIOUS DISEASES
- Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity
- (2013) Yosuke Suzuki et al. CLINICA CHIMICA ACTA
- Optimizing antifungal choice and administration
- (2013) David Andes CURRENT MEDICAL RESEARCH AND OPINION
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
- (2013) H. R. Ashbee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies
- (2013) Yeon-Joo Lee et al. MEDICAL MYCOLOGY
- Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
- (2012) Dimitra Mitsani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
- (2012) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- Monitoring of voriconazole plasma concentrations in immunocompromised paediatric patients
- (2012) S. Pieper et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis
- (2012) Yukihiro Hamada et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients
- (2012) Alicia Gómez-López et al. MEDICAL MYCOLOGY
- Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience
- (2012) Zdenek Racil et al. MYCOSES
- Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis
- (2012) Soo-Han Choi et al. PEDIATRIC BLOOD & CANCER
- Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients
- (2011) Peter F. Troke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients
- (2011) Si-Hyun Kim et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study
- (2011) P. Soler-Palacin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinician Ordering Practices for Voriconazole Therapeutic Drug Monitoring: Experiences of a Referral Laboratory
- (2010) Spiros Miyakis et al. THERAPEUTIC DRUG MONITORING
- Voriconazole Pharmacokinetics and Pharmacodynamics in Children
- (2009) Michael Neely et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole concentrations and outcome of invasive fungal infections
- (2009) S. Miyakis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes
- (2009) Kazuaki Matsumoto et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
- (2009) Koki Ueda et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
- (2008) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
- (2008) Brahm H. Segal et al. CLINICAL INFECTIOUS DISEASES
- Retrospective Serological Tests for Determining the Optimal Blood Concentration of Voriconazole for Treating Fungal Infection
- (2008) Toshikatsu OKUDA et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started